Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:GH NYSE:HIMS NASDAQ:LFST NASDAQ:OPCH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGHGuardant Health$54.90-3.3%$53.81$20.14▼$68.00$6.85B1.452.22 million shs2.78 million shsHIMSHims & Hers Health$55.48+7.2%$50.26$15.73▼$72.98$12.54B2.1424.77 million shs35.41 million shsLFSTLifeStance Health Group$5.23-2.1%$4.81$3.74▼$8.61$2.03B1.171.97 million shs1.25 million shsOPCHOption Care Health$28.48-3.0%$29.09$21.39▼$35.53$4.62B0.831.86 million shs1.63 million shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGHGuardant Health0.00%-8.70%-6.76%+11.36%+104.93%HIMSHims & Hers Health0.00%+14.65%+20.37%-7.31%+234.82%LFSTLifeStance Health Group0.00%-2.61%-3.86%+1.16%-24.64%OPCHOption Care Health0.00%-2.10%+0.56%-10.50%-10.97%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGHGuardant Health$54.90-3.3%$53.81$20.14▼$68.00$6.85B1.452.22 million shs2.78 million shsHIMSHims & Hers Health$55.48+7.2%$50.26$15.73▼$72.98$12.54B2.1424.77 million shs35.41 million shsLFSTLifeStance Health Group$5.23-2.1%$4.81$3.74▼$8.61$2.03B1.171.97 million shs1.25 million shsOPCHOption Care Health$28.48-3.0%$29.09$21.39▼$35.53$4.62B0.831.86 million shs1.63 million shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGHGuardant Health0.00%-8.70%-6.76%+11.36%+104.93%HIMSHims & Hers Health0.00%+14.65%+20.37%-7.31%+234.82%LFSTLifeStance Health Group0.00%-2.61%-3.86%+1.16%-24.64%OPCHOption Care Health0.00%-2.10%+0.56%-10.50%-10.97%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGHGuardant Health 3.06Buy$58.246.08% UpsideHIMSHims & Hers Health 1.92Reduce$38.92-29.85% DownsideLFSTLifeStance Health Group 2.86Moderate Buy$8.5062.52% UpsideOPCHOption Care Health 2.89Moderate Buy$35.7525.53% UpsideCurrent Analyst Ratings BreakdownLatest LFST, HIMS, OPCH, and GH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/12/2025HIMSHims & Hers HealthCanaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$68.009/4/2025GHGuardant HealthBTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$65.00 ➝ $70.008/19/2025HIMSHims & Hers HealthZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold8/18/2025HIMSHims & Hers HealthTruist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetHold$48.00 ➝ $37.008/8/2025LFSTLifeStance Health GroupUBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$8.50 ➝ $9.008/5/2025HIMSHims & Hers HealthNeedham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold7/31/2025OPCHOption Care HealthJMP SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetMarket Outperform$36.00 ➝ $38.007/31/2025OPCHOption Care HealthCitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform7/31/2025GHGuardant HealthScotiabankSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetSector Outperform$57.00 ➝ $60.007/31/2025GHGuardant HealthRaymond James FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$59.00 ➝ $61.007/25/2025LFSTLifeStance Health GroupBTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$8.00(Data available from 9/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGHGuardant Health$739.02M9.26N/AN/A($1.13) per share-48.58HIMSHims & Hers Health$1.48B8.49$0.35 per share157.60$2.16 per share25.69LFSTLifeStance Health Group$1.25B1.63$0.04 per share131.89$3.78 per share1.38OPCHOption Care Health$5.00B0.92$1.65 per share17.31$8.25 per share3.45Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGHGuardant Health-$436.37M-$3.35N/AN/AN/A-49.93%N/A-28.95%11/5/2025 (Estimated)HIMSHims & Hers Health$126.04M$0.8069.35106.693.759.63%26.26%13.06%11/3/2025 (Estimated)LFSTLifeStance Health Group-$57.44M-$0.05N/AN/AN/A-1.23%-1.11%-0.76%11/6/2025 (Estimated)OPCHOption Care Health$211.82M$1.2522.7822.601.733.93%17.53%7.17%10/29/2025 (Estimated)Latest LFST, HIMS, OPCH, and GH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025LFSTLifeStance Health Group-$0.03-$0.01+$0.02-$0.01$345.05 million$345.31 million8/4/2025Q2 2025HIMSHims & Hers Health$0.18$0.17-$0.01$0.17$550.06 million$544.83 million7/30/2025Q2 2025GHGuardant Health-$0.52-$0.44+$0.08-$0.80$211.19 million$232.09 million7/30/2025Q2 2025OPCHOption Care Health$0.40$0.41+$0.01$0.31$1.35 billion$1.42 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGHGuardant HealthN/AN/AN/AN/AN/AHIMSHims & Hers HealthN/AN/AN/AN/AN/ALFSTLifeStance Health GroupN/AN/AN/AN/AN/AOPCHOption Care HealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGHGuardant HealthN/A3.713.35HIMSHims & Hers Health1.724.984.46LFSTLifeStance Health Group0.191.481.48OPCHOption Care Health0.811.521.00Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGHGuardant Health92.60%HIMSHims & Hers Health63.52%LFSTLifeStance Health Group85.50%OPCHOption Care Health98.05%Insider OwnershipCompanyInsider OwnershipGHGuardant Health6.10%HIMSHims & Hers Health17.71%LFSTLifeStance Health Group6.60%OPCHOption Care Health0.64%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGHGuardant Health2,021124.71 million117.10 millionNot OptionableHIMSHims & Hers Health1,637226.02 million185.99 millionOptionableLFSTLifeStance Health Group10,218388.94 million363.27 millionOptionableOPCHOption Care Health8,088162.29 million161.26 millionOptionableLFST, HIMS, OPCH, and GH HeadlinesRecent News About These CompaniesOption Care Health, Inc. $OPCH Shares Bought by Intech Investment Management LLC4 hours ago | marketbeat.comCaxton Associates LLP Invests $429,000 in Option Care Health, Inc. $OPCH5 hours ago | marketbeat.comDynamic Technology Lab Private Ltd Makes New $583,000 Investment in Option Care Health, Inc. $OPCHSeptember 13 at 3:59 AM | marketbeat.comAlliancebernstein L.P. Has $19.95 Million Stock Holdings in Option Care Health, Inc. $OPCHSeptember 13 at 3:32 AM | marketbeat.comOption Care Health (NASDAQ:OPCH) Director Purchases $99,976.41 in StockSeptember 12 at 5:52 PM | marketbeat.comInsider Move: Norman Wright Invests $99K In Option Care Health StockSeptember 12 at 2:17 AM | benzinga.comNorman Wright Buys 3,411 Shares of Option Care Health (NASDAQ:OPCH) StockSeptember 11, 2025 | insidertrades.comMillennium Management LLC Grows Holdings in Option Care Health, Inc. $OPCHSeptember 11, 2025 | marketbeat.comAxiom Investors LLC DE Buys 190,417 Shares of Option Care Health, Inc. $OPCHSeptember 10, 2025 | marketbeat.comSciencast Management LP Increases Holdings in Option Care Health, Inc. $OPCHSeptember 10, 2025 | marketbeat.comTeza Capital Management LLC Has $577,000 Holdings in Option Care Health, Inc. $OPCHSeptember 10, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Acquires New Shares in Option Care Health, Inc. $OPCHSeptember 10, 2025 | marketbeat.comAmundi Cuts Position in Option Care Health, Inc. $OPCHSeptember 10, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Raises Stock Position in Option Care Health, Inc. $OPCHSeptember 10, 2025 | marketbeat.comOption Care Health, Inc. (NASDAQ:OPCH) is a favorite amongst institutional investors who own 66%September 9, 2025 | finance.yahoo.comOption Care Health, Inc. $OPCH Shares Sold by Park West Asset Management LLCSeptember 8, 2025 | marketbeat.comOption Care Health (NASDAQ:OPCH) vs. LifeStance Health Group (NASDAQ:LFST) Head-To-Head AnalysisSeptember 8, 2025 | americanbankingnews.comOption Care Health, Inc. $OPCH Shares Bought by Raymond James Financial Inc.September 6, 2025 | marketbeat.comDurable Capital Partners LP Invests $122.91 Million in Option Care Health, Inc. $OPCHSeptember 3, 2025 | marketbeat.comCubist Systematic Strategies LLC Takes $12.38 Million Position in Option Care Health, Inc. $OPCHSeptember 3, 2025 | marketbeat.comAmerican Century Companies Inc. Sells 1,223,779 Shares of Option Care Health, Inc. $OPCHSeptember 3, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesBuffett Makes Big Moves Outside of UNH: A Buy and Sell BreakdownBy Leo Miller | August 18, 20253 Robotics Stocks at the Heart of the Robotics RevolutionBy Chris Markoch | August 21, 2025NIO Just Got Its Second Upgrade of the Month, and It’s BigBy Sam Quirke | August 28, 2025Insiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift4By Leo Miller | August 18, 2025Ozempic Boom: Hims & Eli Lilly Lead Healthcare BetsBy Gabriel Osorio-Mazilli | August 21, 2025LFST, HIMS, OPCH, and GH Company DescriptionsGuardant Health NASDAQ:GH$54.90 -1.89 (-3.33%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$56.16 +1.27 (+2.30%) As of 08:16 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.Hims & Hers Health NYSE:HIMS$55.48 +3.72 (+7.19%) Closing price 09/12/2025 03:59 PM EasternExtended Trading$54.57 -0.91 (-1.64%) As of 08:24 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.LifeStance Health Group NASDAQ:LFST$5.23 -0.11 (-2.06%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$5.34 +0.11 (+2.08%) As of 04:07 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.Option Care Health NASDAQ:OPCH$28.48 -0.89 (-3.03%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$29.02 +0.54 (+1.88%) As of 04:08 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 09/08 - 09/12 Wall Street Eyes +30% Upside in Synopsys After Huge Earnings Fall Meta's $600B U.S. Investment: Bearish or Bullish for Shares? Football Season Is Here and DraftKings Stock Is Surging RH Stock Slides After Mixed Earnings and Tariff Concerns Post Onum Deal: Is CrowdStrike Ready to Rebound After 16% Drop? Chewy’s September Pullback: Is It Your Time to Buy? It’s Time to Buy the Dip in Kroger Stock Price Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
